Because haematological cells, both cancer and primary cells, have clear responses to treatment with APIM-peptides [3, 10], F in KFAGR in ENO1 was mutated in the haploid chronic myeloid leukaemia cell line HAP1. This evidence concerns the gene ENO1 and chronic myelogenous leukemia, BCR-ABL1 positive.